Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS016 vs Humira in active ankylosing spondylitis
CTR20160398Phase 3Completed
- Sponsor
- Zhejiang Hisun Pharmaceutical Co., Ltd.
- Start
- Aug 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of anjianning in ankylosing spondylitis (AS), sponsored by Zhejiang Hisun Pharmaceutical Co., Ltd.. Started Aug 2016; status: completed.
02
Drugs
anjianning
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on CTR20160398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160398.